AngioDynamics, Inc.
ANGO
$10.36
$0.383.81%
NASDAQ
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.92% | -5.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.92% | -5.55% | |||
| Cost of Revenue | 2.35% | -10.77% | |||
| Gross Profit | 6.99% | -0.86% | |||
| SG&A Expenses | -9.27% | 10.93% | |||
| Depreciation & Amortization | -0.38% | 2.51% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.02% | -0.22% | |||
| Operating Income | 68.47% | -117.40% | |||
| Income Before Tax | 41.36% | -77.38% | |||
| Income Tax Expenses | -107.69% | 208.33% | |||
| Earnings from Continuing Operations | 41.76% | -80.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 41.76% | -80.21% | |||
| EBIT | 68.47% | -117.40% | |||
| EBITDA | 273.43% | -56.50% | |||
| EPS Basic | 42.26% | -79.40% | |||
| Normalized Basic EPS | 66.67% | -103.48% | |||
| EPS Diluted | 42.26% | -76.18% | |||
| Normalized Diluted EPS | 66.67% | -103.48% | |||
| Average Basic Shares Outstanding | 0.89% | 0.46% | |||
| Average Diluted Shares Outstanding | 0.89% | 0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||